Alfuzosin for treatment of benign prostatic hypertrophy
Authors:
- H. BensadounHBH. Bensadoun
- M.C. Delauche-CavallierMDM.C. Delauche-Cavallier
- P. AttatliPAP. Attatli
- The BPH-ALF GroupTGThe BPH-ALF Group
- 1 June 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 337 (8755) , 1457-1461
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Mortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaNew England Journal of Medicine, 1989
- Bladder-neck opening test in spinal cord injury patients using a new i.v. alpha-blocking agent, alfuzosinSpinal Cord, 1989
- Indoramin—an Effective New Drug in the Management of Bladder Outflow ObstructionBritish Journal of Urology, 1987
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- Identification of the Poor Risk Patient with “Prostatism” and Detrusor FailureBritish Journal of Urology, 1986
- A Double‐blind Controlled Trial of a New α‐1 Blocking Drug in the Treatment of Bladder Outflow ObstructionBritish Journal of Urology, 1985
- Bladder Outflow Obstruction Treated with PhenoxybenzamineBritish Journal of Urology, 1982
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978
- The Adrenergic Component in the Proximal UrethraUrologia Internationalis, 1977
- Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder NeckBritish Journal of Urology, 1975